• Pitfall #2: Not Considering Frequency in Your URRA

    by Liz Mauer, MHCI This is the third in a multipart series about how to effectively identify, understand, and communicate a product’s use-related risks. It can be hard to know how to make use of frequency of occurrence ratings when creating URRAs. On the one hand, the FDA (in their 2016 Human Factors Guidance), clearly […]

    Read More